neural plate
Summary
The neural plate is a thickened, specialized region of ectoderm that forms during the third week of embryogenesis in response to signals from the underlying notochord. It is the precursor structure to the entire central nervous system, giving rise to the neural tube and neural crest cells. Failure of proper neural plate development or neurulation leads to neural tube defects.
Detail
The neural plate arises from surface ectoderm through a process called neural induction, driven by the notochord which secretes BMP antagonists (Noggin, Chordin, Follistatin) that inhibit BMP4 signaling, allowing ectoderm to differentiate into neuroectoderm rather than epidermis. This occurs around day 18-19 of development (week 3). The neural plate is initially a flat sheet of columnar cells located dorsal to the notochord along the embryonic midline.
As development proceeds, the lateral edges of the neural plate elevate to form neural folds, while the midline depresses to form the neural groove. The neural folds then approach each other and fuse in the midline, converting the neural plate into the neural tube through the process of neurulation (also called primary neurulation for cranial and mid-body segments). This fusion begins in the cervical region and proceeds bidirectionally (cranially and caudally), closing at the anterior neuropore (~day 25) and posterior neuropore (~day 27-28).
Cells at the junction between the neural plate and surface ectoderm form the neural crest, a critical population that migrates extensively to form diverse structures including dorsal root ganglia, autonomic ganglia, Schwann cells, melanocytes, adrenal medulla, and craniofacial bones/cartilage (via cranial neural crest).
Clinical significance: Failure of the neural folds to fuse properly (failure of neuropore closure) results in neural tube defects (NTDs). Anterior neuropore closure failure causes anencephaly, while posterior neuropore closure failure causes spina bifida (ranging from spina bifida occulta to myelomeningocele). Maternal folic acid deficiency significantly increases NTD risk, which is why folate supplementation (400 mcg/day) is recommended for women of childbearing age. Valproic acid and other antiepileptic drugs are teratogenic and inhibit folate metabolism, increasing NTD risk. Elevated maternal serum alpha-fetoprotein (AFP) and amniotic fluid AFP/acetylcholinesterase are used for prenatal screening of NTDs.
Sources
- Langman's Medical Embryology
- BRS Embryology
- First Aid for the USMLE Step 1
- Moore's The Developing Human
Reviewed by AnkiBoss editorial — medical student review. Information here is for study reference only and is not medical advice. Spotted an error? Let us know.